Qualité des preuves 4.63/5
Score d’évaluation en huit dimensions selon la grille de qualité . Chaque dimension notée de 1 à 5.
- D1 Ancrage des sources
- 4/5
- D2 Autorité des sources
- 5/5
- D3 Arithmétique
- 5/5
- D4 Incertitude
- 4/5
- D5 Portée
- 5/5
- D6 Prose
- 5/5
- D7 Honnêteté sur la perception
- 4/5
- D8 Complétude des réserves
- 5/5
Comment le risque varie
Le chiffre principal est une moyenne sur des situations très différentes. Voici comment la probabilité varie selon le scénario ou le contexte :
1 sur 1 000 000
Structural floor. Ambient RF power density from cell towers at ground level is typically 1,000-10,000x below ICNIRP general public limits. No epidemiological study has found elevated cancer incidence in populations living near base stations. Multiple ecological studies (UK, Germany, Israel) have looked; none found a signal after controlling for confounders.
1 sur 200 000
Placeholder reflecting the INTERPHONE top-decile finding (OR 1.40 for glioma) which the study authors attributed to bias. If the association were causal, the absolute risk increase over a baseline lifetime glioma rate of ~0.6% would be small. The FDA and WHO do not consider this finding sufficient to establish causation.
1 sur 333 333
Telecom workers installing and maintaining antennas can experience near-field exposures closer to ICNIRP occupational limits. Occupational studies have not found consistent cancer elevation, but sample sizes are small. ICNIRP occupational limits are set with a 50x reduction factor below thermal thresholds.
1 sur 1 000 000
mmWave radiation is absorbed in the outer layers of skin and does not penetrate to internal organs. ICNIRP 2020 guidelines explicitly cover these frequencies. No epidemiological data exists for mmWave-specific cancer risk because population-scale exposure only began in 2020. The physics of shallow penetration depth makes internal organ effects implausible at guideline-compliant levels.
La longueur et la teinte de la barre classent ces scénarios les uns par rapport aux autres, pas par rapport à d'autres risques. Les probabilités exactes sont indiquées à côté de chacun.
La base de preuves concernant les RF-EMF et le cancer est exceptionnellement polarisée entre les organismes de réglementation. Le CIRC a classé les champs électromagnétiques de radiofréquence dans le Groupe 2B (« possiblement cancérogènes ») en 2011, se basant principalement sur la découverte de l’étude INTERPHONE d’un risque de gliome accru de 40 % dans le décile le plus élevé d’utilisation cumulative du téléphone — un résultat que les auteurs de l’étude eux-mêmes ont déclaré ne pas pouvoir être interprété de manière causale en raison du biais de mémorisation et du biais de sélection. Le rapport de cotes global d’INTERPHONE pour le gliome était en fait inférieur à 1,0 (OR 0,81), suggérant un effet protecteur que tout le monde s’accorde à considérer comme un artefact. Pendant ce temps, l’examen de la FDA de 2020, le projet EMF de l’OMS, la mise à jour des lignes directrices de l’ICNIRP de 2020 et le 18e rapport du UK COMARE ont tous conclu que le poids des preuves ne soutient pas de lien causal entre l’exposition aux RF-EMF à des niveaux conformes aux lignes directrices et le cancer. Les lignes directrices de l’ICNIRP de 2020 couvrent explicitement les fréquences 5G jusqu’à 300 GHz et n’ont trouvé aucune base scientifique pour réviser les limites d’exposition de 1998, se contentant de restructurer leur forme pour plus de clarté.
Ce qui rend la peur de la 5G distinctive est moins la science que la sociologie. Le déploiement a coïncidé avec la pandémie de COVID-19, et les théories du complot liant les deux ont entraîné des incendies criminels sur des dizaines de pylônes cellulaires au UK, en Irlande et aux Pays-Bas début 2020. La classification 2B du CIRC — conçue comme une étiquette d’identification des dangers, et non comme une quantification des risques — a été systématiquement dépouillée de son contexte et présentée comme la preuve que « l’OMS dit que les téléphones portables causent le cancer ». Le Groupe 2B contient plus de 300 agents, y compris l’extrait de feuille entière d’aloe vera, les légumes marinés et le talc ; cela signifie qu’il existe des preuves limitées qui ne peuvent être écartées, et non qu’un risque a été établi. La distinction entre le cadre du CIRC (qui demande « cela pourrait-il causer le cancer dans n’importe quel scénario d’exposition ? ») et l’évaluation des risques de l’OMS (qui demande « cela cause-t-il le cancer à des niveaux réels ? ») est subtile et systématiquement perdue dans la couverture médiatique.
Pour la sous-question du téléphone dans la poche, l’entrée sur l’exposition testiculaire à la chaleur sur ce site couvre la voie de preuve la plus solide : les effets thermiques sur les paramètres du sperme dus à la chaleur de l’appareil, et non la cancérogenèse spécifique aux RF. La méta-analyse de Adams de 2014 a trouvé une réduction de la motilité de 8,1 % associée à l’exposition au téléphone, mais les intervalles de confiance sont larges, les études incluses mélangent l’irradiation in vitro avec des auto-déclarations observationnelles, et aucune étude n’a mesuré les résultats de fertilité. L’American Cancer Society ne répertorie pas les RF-EMF parmi les facteurs de risque de cancer testiculaire. Pour la 5G spécifiquement, les fréquences millimétriques (24-39 GHz) sont absorbées dans les couches externes de la peau et ne pénètrent pas les organes internes — une contrainte physique qui rend le risque de cancer interne invraisemblable aux niveaux de puissance conformes à l’ICNIRP, bien que les données épidémiologiques à l’échelle de la population à ces fréquences n’existent pas encore car le déploiement est trop récent.
Pour aller plus loin
Les tours 5G emettent un rayonnement non ionisant a des niveaux des milliers de fois inferieurs aux limites de securite. Aucun mecanisme biologique plausible de dommage n'existe. L'OMS, la FDA et l'ICNIRP sont d'accord. L'anxiete est reelle. Le risque ne l'est pas.
Registre des sources
Chaque chiffre ci-dessous correspond à ce que la source a rapporté, avec la citation textuelle sur laquelle nous nous sommes appuyés et la méthode de calcul. Cliquez sur un lien pour vérifier directement.
1/6 sources vérifiées de manière indépendante, mot pour mot, par rapport à la source citée
-
[1] International Agency for Research on Cancer (WHO/IARC) — IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans
IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans- Statistique
RF-EMF classified as Group 2B ('possibly carcinogenic to humans') based on limited evidence of glioma in heavy mobile phone users- Extrait
“"The evidence was reviewed critically, and overall evaluated as being limited2 among users of wireless telephones for glioma and acoustic neuroma, and inadequate3 to draw conclusions for other types of cancers. The evidence from the occupational and environmental exposures mentioned above was similarly judged inadequate. The Working Group did not quantitate the risk; however, one study of past cell phone use (up to the year 2004), showed a 40% increased risk for gliomas in the highest category of heavy users (reported average: 30 minutes per day over a 10-year period)." ”
- Données source de
- 2011-05-31
- Consulté le
- 2026-04-18 · copie archivée
- Calcul
- The IARC Monograph 102 Working Group evaluated RF-EMF based primarily on the Interphone study (2010) and Hardell group case-control studies. The 40% glioma increase was observed only in the highest decile of cumulative call time in Interphone, and the Interphone authors themselves cautioned that recall bias and selection bias could account for the finding. Group 2B is IARC's second-lowest risk category — it indicates limited evidence in humans and less than sufficient evidence in animals. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and occupational dry cleaning. The classification does not constitute a risk quantification.
-
[2] International Commission on Non-Ionizing Radiation Protection (ICNIRP) — Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)
Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)- Statistique
ICNIRP 2020 guidelines set exposure limits with large safety factors; 5G frequencies (sub-6 GHz and mmWave up to 300 GHz) remain non-ionizing and within the same framework- Extrait
“"This document presents these revised Guidelines, which provide protection for humans from exposure to EMFs from 100 kHz to 300 GHz. … Reduction factors account for biological variability in the population (e.g., age, sex), variation in baseline conditions (e.g., tissue temperature), variation in environmental factors (e.g., air temperature, humidity, clothing), dosimetric uncertainty associated with deriving exposure values, uncertainty associated with the health science, and as a conservative measure more generally." ”
- Données source de
- 2020-03-11
- Consulté le
- 2026-04-18 · copie archivée
- Calcul
- ICNIRP's 2020 update reviewed the entire post-1998 literature, including studies at frequencies used by 5G (sub-6 GHz and mmWave 24-300 GHz). The guidelines explicitly cover 5G frequencies. The only confirmed health effect at these frequencies is tissue heating, and the exposure limits incorporate reduction factors of 50x (occupational) to 200x (general public) below thresholds where thermal effects begin. Actual 5G small cell power output is typically lower per base station than 4G macro towers because of the densified architecture. ICNIRP is the independent scientific body whose guidelines are adopted by most national regulators outside the US (the FCC uses IEEE standards that reach similar conclusions).
-
[3] The Lancet Oncology / INTERPHONE Study Group — Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study
Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study- Statistique
No overall increased risk of glioma or meningioma with mobile phone use; OR 0.81 (95% CI 0.70-0.94) for glioma overall; elevated OR 1.40 (95% CI 1.03-1.89) only in the highest decile of cumulative call time- Extrait
“"Overall, no increase in risk of glioma or meningioma was observed with use of mobile phones. There were suggestions of an increased risk of glioma at the highest exposure levels, but biases and error prevent a causal interpretation." ”
- Données source de
- 2010-05-17
- Consulté le
- 2026-04-18
- Calcul
- The INTERPHONE study is the largest case-control study of cell phone use and brain tumors, covering 13 countries with 2,708 glioma cases and 2,409 meningioma cases. The overall odds ratio for glioma was protective (0.81), which the authors attributed to participation bias. The elevated OR in the top decile (1.40) is the primary finding that drove the IARC 2B classification. The authors explicitly stated that "biases and error prevent a causal interpretation" of the top-decile result. The study covered phone use up to 2004 — before 4G, let alone 5G — and measured cumulative call time, not ambient tower exposure.
- Indépendance
- INTERPHONE is the primary study underlying the IARC classification; the IARC source above is a downstream interpretation of this and other data. They are not independent but serve different roles — INTERPHONE provides the data, IARC provides the regulatory classification.
-
[4] US Food and Drug Administration — Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)
Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)- Statistique
FDA concluded that the weight of scientific evidence does not support the conclusion that non-ionizing RF energy from cell phones causes cancer- Extrait
“"Based on the evaluation of the currently available information, the FDA believes that the weight of the scientific evidence does not support an increase in health risks from radio frequency exposure from cell phone use at or below the radio frequency exposure limits set by the FCC." ”
- Données source de
- 2020-02-10
- Consulté le
- 2026-06-30 · copie archivée
- Calcul
- The FDA's 2020 review covered epidemiological, animal, and in vitro studies published between 2008 and 2018. The review explicitly addressed the NTP (National Toxicology Program) rat study, which found some evidence of schwannoma in male rats exposed to whole-body RF at SAR levels 2-8x the human safety limit for 9 hours/day over 2 years. The FDA concluded that the NTP results were not generalizable to human cell phone use because of the vastly higher exposure levels and whole-body irradiation protocol. This is the US regulatory counterpart to ICNIRP; both bodies reached the same conclusion using different review processes.
- Indépendance
- The FDA review is an independent US regulatory assessment. It evaluates some of the same underlying studies as IARC Monograph 102 but applies a different weight-of-evidence framework and reaches a distinct conclusion about the sufficiency of evidence for a causal link.
-
[5] World Health Organization — Electromagnetic fields and public health: mobile phones
Electromagnetic fields and public health: mobile phones- Statistique
WHO states that there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health- Extrait
“"Despite extensive research, to date there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health. … The user of a mobile phone encounters field levels that are much higher than any levels in the normal living environment. However, even these increased levels do not appear to generate harmful effects." ”
- Données source de
- 2014-10-08
- Consulté le
- 2026-04-18 · copie archivée
- Calcul
- The WHO EMF Q&A page is the most widely cited public-health summary on mobile phone safety. It post-dates the IARC 2B classification and explicitly notes that the overall evidence does not suggest detrimental effects. WHO's own position — "no evidence to conclude that exposure to low level electromagnetic fields is harmful" — is more conservative than the Group 2B label, reflecting the difference between IARC's hazard identification framework (which asks "could this ever cause cancer under any conditions?") and WHO's risk assessment framework (which asks "does this cause cancer at real-world exposure levels?").
-
[6] Environment International (Adams, Galloway, Mondal, Esteves & Mathews, 2014) — Effect of mobile telephones on sperm quality: a systematic review and meta-analysis Vérifié
Effect of mobile telephones on sperm quality: a systematic review and meta-analysisVoir les 2 fiches Likelier qui citent cette source →
- Statistique
Meta-analysis of 10 studies (1,492 samples) found mobile phone exposure associated with an 8.1% reduction in sperm motility (mean difference -8.1%, 95% CI -13.1 to -3.2)- Extrait
“"Exposure to mobile phones was associated with reduced sperm motility (mean difference -8.1% (95% CI -13.1, -3.2))." ”
- Données source de
- 2014-09-01
- Consulté le
- 2026-07-03 · copie archivée
- Vérification
- Extrait récupéré et confirmé de manière indépendante, mot pour mot, par rapport à la source citée lors de notre audit de vérification.
- Calcul
- Adams et al. (2014, Environment International) pooled 10 studies covering 1,492 semen samples, mixing in vitro irradiation experiments with observational self-report studies. This is the source for the "8.1% motility reduction" figure cited in the body's phone-in-pocket aside; the wide confidence interval (-13.1 to -3.2) is why the body describes the finding as uncertain. No study in the meta-analysis measured actual fertility or conception outcomes, only semen parameters. This source is unrelated to this entry's own cancer-risk conclusion — it backs only the tangential thermal/sperm-quality mention, which is covered in full on the separate testicular-heat-exposure entry.